Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Longeveron Inc. Class A Common Stock
LGVN | US
0.76
USD-0.01
-1.30%
LGVN | US
About Longeveron Inc. Class A Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
0.76
Open
0.79
High
0.79
Low
0.75
Longeveron Inc. a clinical stage biotechnology company develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young healthy adult donors. It is conducting Phase 1 Phase 2a and Phase 2b clinical trials in various indications such as aging-related frailty alzheimer's disease metabolic syndrome acute respiratory distress syndrome and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami Florida.
View LessLGVN | US
Risk
75.3
Sharpe
-0.37
Luna's Score
51/100
Recommendation
Hold
Luna says (LGVN | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
82.4%1 month
75.3%3 months
164.3%6 months
127.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.13
Debt to equity
0.12
Debt to assets
0.09
Ent. to EBITDA
-49.61
Ent. to rev.
17.17
PEG
-
Other Fundamentals
EBITDA
-17.22M
MarketCap
10.91M
MarketCap(USD)
10.91M
Div. yield
-
Op. margin
-747.86
Erngs. growth
-
Rev. growth
115.70
Ret. on equity
-142.16
Short ratio
1.60
Short perc.
6.01
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.19
Range1M
0.25
Range3M
0.76
Volumes: Market Activity
Rel. volume
0.46
Price X volume
149.65K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -49.61 | - | Cheaper |
| Ent. to Revenue | 17.17 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.13 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 164.33 | - | Riskier |
| Debt to Equity | 0.12 | -1.23 | Expensive |
| Debt to Assets | 0.09 | 0.25 | Cheaper |
| Market Cap | 10.91M | - | Emerging |
